(TAAT CEO, Setti Coscarella. Image via TAAT Lifestyle & Wellness Ltd.)
If you look at one set of market headlines around COVID-19, you would read about stimulus packages, vaccine rollouts, and a general lightening in sentiment … but if you look news outlets, you see stories about new variants, rising mortality numbers, and unemployment.
So who’s right about the state of the global economy? On a numbers basis, the former holds true, as stock markets have started to recover some lost ground. On a long-term basis, the full effects can only be estimated for now.
However, amidst the confusion, investors on Stockhouse had plenty of other concerns. One was a bump for the cannabis market, another was the constant search for small-cap opportunities.
Always a solid metric to gauge investor sentiment is what people on the Stockhouse Bullboards are talking about, so let’s dive in and see what the story was this past week ….
Canadian cannabis licensed producer
Aphria Inc. (TSX: APHA, Forum) has appointed its Chief Strategy Officer,
Denise Faltischek, to also assume the role of Managing Director of
Aphria Germany. She joined Aphria in back September 2019 with extensive consumer-packaged goods experience and expertise leading over 50 acquisitions. Now she leads Aphria’s global business strategy and oversees Aphria’s medical and international business segments as well as quality function.
Canopy Growth Corp. (TSX:WEED, Forum) released some positive news this week, via its fiscal
Q3 2021 report, it noted that improved commercial and operational execution drove record net revenue of $153 million, which was up 23% versus Q3 2020.
Toronto-based
Aleafia Health Inc. (TSX-V: ALEF, Forum) stated that it is repaying a
$25-million debt with cash. The transaction amounts to a full repayment of its eight-per-cent unsecured convertible debt. ALEF also announced record cannabis net revenue realized in the quarter ended December 31, 2020.
The cannabis news isn’t limited just to the cannabis sector either this week, taking a look to health care ….
The Supreme Cannabis Company Inc. (TSX: FIRE, Forum) has announced that it had closed its marketed public offering of 121,049,000 units of the company for aggregate gross proceeds of
$22,999,310 (CAD). The net proceeds from this offering will be used to fund growth initiatives, as a reserve for strategic opportunities, and for working capital and general corporate purposes.
Looking at our investor pulse poll from the past week, it seems that just over half of you think that the cannabis market is poised to have a breakout year in 2021.
This week, we want to know which metals you are tracking. Silver and gold have been in the news quite a bit regarding their success, while other precious metals, like platinum, are also making moves. Then you have steel, copper, tin, and aluminum … do you follow them all, or a select few, or just one? Let us know your thoughts by clicking the poll below.
(Click image to vote.)
TAAT Lifestyle & Wellness Ltd. (CSE: TAAT, Forum) has spent the early weeks and months of the year establishing its intellectual property portfolio in all relevant global jurisdictions. To do so, TAAT has placed its flagship product TAAT under the representation of
CROSSMARK, Inc., a Texas-based sales agency that serves retail channels across North America as well as Canada.
Besides food, beverage, and household products in the consumer packaged goods category, CROSSMARK has also had success in commercializing tobacco category offerings in the United States, which plays right into the tobacco-alternative that TAAT is offering.
The intent by TAAT is to leverage the existing relationships that CROSSMARK had established with more than 100,000 convenience retailers to expand availability of TAAT in Ohio and potentially elsewhere across the United States.
The word is already getting out about TAAT, as its Chief Executive Officer Setti Coscarella (pictured above) discussed this partnership with CROSSMARK and his company’s value proposition in an interview with
Forbes magazine.
CEO Coscarella commented,
“Obtaining coverage of TAAT in a national mainstream news outlet such as Forbes is a tremendous milestone because it demonstrates positive reception and validation of TAAT as a company that is gaining momentum in the $814 billion tobacco industry.”
What the "Buzz"
Our Bullboards have up to 2 Million pageviews a day. Get the inside scoop on conversations around the most significant trends and stock appreciations in our weekly wrap up.
Get "Buzz on the Bullboards" delivered to your inbox every Thursday!
Buzz on the Bullboards | Sign Up Here
2021 has also been a busy month and a half for
Sernova Corp. (TSX-V: SVA, Forum) so far, as it continues to keep its name in the top six for healthcare companies. The clinical-stage regenerative medicine therapeutics company has also seen its work published recently.
On Wednesday’s edition of
The Point, author R. Hutchison admitted that SVA is “not fairly represented in their current market cap” (Sigilon Therapeutics’ $1.4 billion (USD) vs. Sernova’s $307 million (USD)). With a high value lead program on Diabetes, that has shown tremendous results all the way through and into to a Phase I/II study currently occurring at the University of Chicago for which positive interim safety and efficacy data has recently been released.
Boasting a functional cure for Type 1 Diabetes, Sernova a leading clinical-stage regenerative medicine therapeutics company that increased the size of its bought deal financing to an aggregate of 16,700,000 units at a price of $1.20 (CAD) per Unit for gross proceeds to the company of approximately
$20,040,000 (CAD).
2021 has also been a busy month and a half for
Sernova Corp. (TSX-V: SVA, Forum) so far, as it continues to keep its name in the top six for healthcare companies. The clinical-stage regenerative medicine therapeutics company has also seen its work published recently.
On Wednesday’s edition of
The Point, author R. Hutchison admitted that SVA is “not fairly represented in their current market cap” (Sigilon Therapeutics’ $1.4 billion (USD) vs. Sernova’s $307 million (USD)). With a high value lead program on Diabetes, that has shown tremendous results all the way through and into to a Phase I/II study currently occurring at the University of Chicago for which positive interim safety and efficacy data has recently been released.
Boasting a functional cure for Type 1 Diabetes, Sernova a leading clinical-stage regenerative medicine therapeutics company that increased the size of its bought deal financing to an aggregate of 16,700,000 units at a price of $1.20 (CAD) per Unit for gross proceeds to the company of approximately
$20,040,000 (CAD).
PyroGenesis Canada Inc. (TSX-V.PYR, Forum) continues to make waves, having just filed a
Form 40-F Registration Statement with the United States Securities and Exchange Commission.
Filed in connection with its application to list its common shares on the NASDAQ Stock Exchange (the second-largest exchange by market cap worldwide) This registration statement is expected to help the company advance its operations to design develop, manufacture, and commercialize plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products. The NASDAQ also holds many of the world’s biggest technology companies, so PyroGenesis would be right at home among them and its offerings would be exposed to a much wider investment audience.
(PyroGenesis Stock Chart – August 2020 to February 2021. Click to enlarge.)
Meanwhile, the COVID-19 pandemic continues to impede our daily lives and the economy alike, but Canadian tech company
Kontrol Energy Corp. (CSE: KNR, Forum) just announced that that the Ontario government is providing $2 million (CAD) to its London based subsidiary,
CEM Specialties Inc., to help commercialize and accelerate production of Kontrol BioCloud, a COVID-19 detector. The BioCloud is a real-time analyzer designed to detect airborne viruses. This funding was made possible by the Ontario Together Fund.
Finally, ever since Reddit users managed to change the way traders looked at stocks by driving up the value of shares of companies,
Datametrex AI Ltd. (TSX-V: DM, Forum) has been working on an artificial intelligence (AI) solution to help people understand this trend better.
DM announced that its platform
NexaSMART (Social Media Automated Reporting Technology) will allow for a deeper analysis and understanding of how social media can influence over stock prices. Nexalogy will soon add Reddit and other data sources in order to expand AI interpretation of such trends. It can summarize stock winners and losers and the gist of discussions without human input.
The Company’s Chief Executive Officer, Marshall Gunter stated that data collection began at the end of January.
“We are happy to report that NexaSMART will include Reddit and other data sources as of Q2 2021. This will expand our offering and capitalize of the new information environment reflected in the Reddit events.”
Next week is a long weekend for American markets and for many Canadians, which should give us a bit of a breather in terms of massive market shakeups. However, it also gives us an extra day to reflect, think, and generate new discussions on hot investment sectors on the Stockhouse Bullboards. For previous editions of Buzz on the Bullboards:
click here.
FULL DISCLOSURE: Datametrex AI Ltd. and PyroGenesis Canada Inc. are clients of Stockhouse Publishing.